Tomohiro Fujii

1.2k total citations
47 papers, 887 citations indexed

About

Tomohiro Fujii is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Tomohiro Fujii has authored 47 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in Tomohiro Fujii's work include Monoclonal and Polyclonal Antibodies Research (14 papers), HER2/EGFR in Cancer Research (13 papers) and Urinary Bladder and Prostate Research (7 papers). Tomohiro Fujii is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), HER2/EGFR in Cancer Research (13 papers) and Urinary Bladder and Prostate Research (7 papers). Tomohiro Fujii collaborates with scholars based in Japan, United States and Malaysia. Tomohiro Fujii's co-authors include Yoshimasa Jo, Atsushi Nagai, Ryoei Hara, Yoshiyuki Miyaji, Yutaka Matsuda, Teruhiko Yokoyama, Norio Kondo, Masato Fujisawa, Junichi Hiratsuka and Brian A. Mendelsohn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Tomohiro Fujii

45 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Fujii Japan 19 310 261 216 189 157 47 887
Joerg Hennenlotter Germany 19 450 1.5× 196 0.8× 371 1.7× 126 0.7× 97 0.6× 72 1.2k
Katsunori Uchida Japan 16 291 0.9× 217 0.8× 225 1.0× 87 0.5× 53 0.3× 78 761
SUSAN D. SWEAT United States 10 565 1.8× 137 0.5× 135 0.6× 296 1.6× 115 0.7× 16 922
Toshifumi Kurahashi Japan 17 476 1.5× 272 1.0× 228 1.1× 35 0.2× 75 0.5× 50 868
W.-D. Beecken Germany 10 185 0.6× 175 0.7× 253 1.2× 128 0.7× 128 0.8× 14 768
Guangxi Sun China 15 344 1.1× 190 0.7× 156 0.7× 51 0.3× 23 0.1× 84 614
Hamilto Yamamoto Brazil 14 137 0.4× 263 1.0× 157 0.7× 32 0.2× 61 0.4× 41 650
Felix Bremmer Germany 18 404 1.3× 198 0.8× 382 1.8× 134 0.7× 20 0.1× 96 1.1k
Antonio Galia Italy 12 229 0.7× 166 0.6× 139 0.6× 61 0.3× 25 0.2× 32 498
Sumio Noguchi Japan 17 303 1.0× 196 0.8× 291 1.3× 110 0.6× 66 0.4× 73 790

Countries citing papers authored by Tomohiro Fujii

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Fujii more than expected).

Fields of papers citing papers by Tomohiro Fujii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Fujii. The network helps show where Tomohiro Fujii may publish in the future.

Co-authorship network of co-authors of Tomohiro Fujii

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Fujii. A scholar is included among the top collaborators of Tomohiro Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Fujii. Tomohiro Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwamoto, Yuichiro, Tomohiko Kimura, Junpei Sanada, et al.. (2025). Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentaloma. Endocrine Journal. 72(10). 1115–1125.
2.
Stofleth, Jason T., et al.. (2025). Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation Strategies. ACS Medicinal Chemistry Letters. 16(7). 1334–1339. 2 indexed citations
3.
Nakamura, Katsuhiko, Yutaka Suehiro, Atsushi Goto, et al.. (2024). A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer. Oncology. 103(4). 1–7. 2 indexed citations
4.
Fujii, Tomohiro, Yutaka Matsuda, Kazutoshi Takahashi, et al.. (2023). AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production. Bioconjugate Chemistry. 42 indexed citations
5.
Matsuda, Yutaka, et al.. (2021). In-situ Reverse Phased HPLC Analysis of Intact Antibody-Drug Conjugates. Analytical Sciences. 37(8). 1171–1176. 25 indexed citations
6.
Hara, Ryoei, et al.. (2019). Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy. Urology Case Reports. 24. 100865–100865. 1 indexed citations
7.
Hara, Ryoei, et al.. (2018). Male squirting: Analysis of one case using color Doppler ultrasonography. IJU Case Reports. 1(1). 19–21. 1 indexed citations
8.
Jo, Yoshimasa, Tomohiro Fujii, Ryoei Hara, et al.. (2011). Salvage high‐dose‐rate brachytherapy for local prostate cancer recurrence after radiotherapy – preliminary results. British Journal of Urology. 109(6). 835–839. 37 indexed citations
10.
Hara, Ryoei, Yoshimasa Jo, Tomohiro Fujii, et al.. (2008). Optimal Approach for Prostate Cancer Detection as Initial Biopsy: Prospective Randomized Study Comparing Transperineal Versus Transrectal Systematic 12-Core Biopsy. Urology. 71(2). 191–195. 129 indexed citations
11.
Ishimura, Takeshi, Atsushi Takenaka, Yutaka Sakai, et al.. (2006). Hydronephrosis caused by intra‐abdominal abscess from cecal perforation by an ingested fish bone. International Journal of Urology. 13(10). 1350–1351. 6 indexed citations
12.
Takenaka, Atsushi, Takeshi Ishimura, Yutaka Sakai, et al.. (2006). Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: A comparative study of 6 and 12 biopsy cores. International Journal of Urology. 13(1). 10–14. 36 indexed citations
13.
Jo, Yoshimasa, Junichi Hiratsuka, Tomohiro Fujii, Atsushi Takenaka, & Masato Fujisawa. (2004). High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Urology. 64(3). 556–560. 18 indexed citations
14.
Otsuki, Takemi, Junichi Kurebayashi, Masako Uno, et al.. (2003). Expression of HER family receptors and effects of anti-HER2-antibody on human myeloma cell lines. International Journal of Oncology. 23(4). 1135–41. 2 indexed citations
15.
Uno, Masako, Takemi Otsuki, Kenichiro Yata, et al.. (2002). Participation of Fas-mediated apoptotic pathway in KB, a human head and neck squamous cell carcinoma cell line, after irradiation. International Journal of Oncology. 20(3). 617–22. 11 indexed citations
16.
Yata, Kenichiro, Haruko Sakaguchi, Masako Uno, et al.. (2002). IL-10 in Myeloma Cells. Leukemia & lymphoma. 43(5). 969–974. 30 indexed citations
17.
Uno, Masako, Takemi Otsuki, Junichi Kurebayashi, et al.. (2001). Anti‐HER2‐antibody enhances irradiation‐induced growth inhibition in head and neck carcinoma. International Journal of Cancer. 94(4). 474–479. 29 indexed citations
18.
Peng, Xiaohua, Jong-Ho Won, Thomas Rutherford, et al.. (2001). The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.. PubMed. 61(11). 4405–13. 50 indexed citations
19.
Jo, Yoshimasa, et al.. (2001). Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. International Journal of Urology. 8(7). 366–373. 25 indexed citations
20.
Fujii, Tomohiro, et al.. (2000). Preclinical Cushing’s syndrome: Report of seven cases and a review of the literature. International Journal of Urology. 7(4). 126–132. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026